Tasso

Tasso

Private
Seattle, WashingtonHealthcare & Life Scienceshttps://www.tassoinc.com

Last Round

Series B

Dec 16, 2021

Total Funding Raised

$126.57M

Momentum Score

25 /100

Company Overview

Tasso is a medical device company that produces innovative blood collection devices designed for easy and painless self-collection of blood samples.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials, Telemedicine, Patient Engagement, Pharma Supply Chain

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

blood collection deviceremote blood collectiondecentralized clinical trialsDCTat-home blood collectionpainless blood collectionon-demand blood collectionsample collection logisticsdried blood spot collectionDBSFDA-cleared deviceremote patient monitoringclinical trial servicesblood lancettelehealth testingcapillary blood collectionPopulation PharmacokineticsPopPK

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Tasso Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Tasso Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BDec 16, 2021
Series AJul 22, 2020
VC RoundMar 5, 2019
SeedDec 6, 2017
GrantSep 28, 2017
Grant
Apr 7, 2015

Key People

Founding team and executive leadership

Erwin Berthier

CTO And Co-Founder

Founding Team

Monica W.

Chief Financial Officer

Executive Team

Tasso Investors

Notable investors and investment history

InvestorRounds
Senvest CapitalSeries B
RA Capital ManagementSeries B
TechstarsSeed, Series A, VC Round
NIH RADxGrant
InCube VenturesSeries B
Merck Global Health Innovation FundSeries A
Foresite CapitalSeries A, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2026

    Olympic anti-doping program is using their products.

  • Feb 26, 2026

    Developing at-home blood testing services in partnership with ARUP.

Tasso Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Tasso Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Tasso's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeattle, Washington
Employee Range98
Year Founded2014
Last FundingDec 16, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.